Cover Image
市場調查報告書

早產兒視網膜症:全球臨床實驗檢討

Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322169
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
早產兒視網膜症:全球臨床實驗檢討 Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 66 Pages
簡介

本報告提供早產兒視網膜症的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 早產兒視網膜症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病臨床實驗上早產兒視網膜症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病臨床實驗上早產兒視網膜症所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

早產兒視網膜症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Shire Plc
    • Mednax, Inc.
    • Insmed Incorporated
    • Gene Signal International SA
    • EyeGene, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Azienda Ospedaliero-Universitaria Meyer
    • Dr. Sami Ulus Children's Hospital
    • Weill Cornell Medical College
    • The Vision Research Foundation
    • University of Miyazaki
    • Oregon Health & Science University
    • IRCCS Policlinico San Matteo
    • University of California, Los Angeles
    • Georgetown University

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2514CTIDB

GlobalData's clinical trial report, "Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014" provides data on the Retinopathy Of Prematurity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinopathy Of Prematurity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinopathy Of Prematurity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Retinopathy Of Prematurity
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Retinopathy Of Prematurity
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Retinopathy Of Prematurity Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Mednax, Inc.
      • Clinical Trial Overview of Mednax, Inc.
      • Insmed Incorporated
      • Clinical Trial Overview of Insmed Incorporated
      • Gene Signal International SA
      • Clinical Trial Overview of Gene Signal International SA
      • EyeGene, Inc.
      • Clinical Trial Overview of EyeGene, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Azienda Ospedaliero-Universitaria Meyer
      • Clinical Trial Overview of Azienda Ospedaliero-Universitaria Meyer
      • Dr. Sami Ulus Children's Hospital
      • Clinical Trial Overview of Dr. Sami Ulus Children's Hospital
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
      • The Vision Research Foundation
      • Clinical Trial Overview of The Vision Research Foundation
      • University of Miyazaki
      • Clinical Trial Overview of University of Miyazaki
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • IRCCS Policlinico San Matteo
      • Clinical Trial Overview of IRCCS Policlinico San Matteo
      • University of California, Los Angeles
      • Clinical Trial Overview of University of California, Los Angeles
      • Georgetown University
      • Clinical Trial Overview of Georgetown University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Region, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, G7 Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, E7 Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Retinopathy Of Prematurity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Mednax, Inc., 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Insmed Incorporated, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Gene Signal International SA, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by EyeGene, Inc., 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero-Universitaria Meyer, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Sami Ulus Children's Hospital, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by The Vision Research Foundation, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miyazaki, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2014*

List of Figures

  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, G7 Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, E7 Countries (%), 2014*
  • Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Retinopathy Of Prematurity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top